Evidence map›Paper›PMID 35419549›Full record

ArticleJournal of photochemistry and photobiology2021

Ruthenium Photosensitizers for NIR PDT Require Lowest-Lying Triplet Intraligand (

Liubov M Lifshits, John A Roque, Elamparuthi Ramasamy, Randolph P Thummel, Colin G Cameron, Sherri A McFarland

Open access · goldAbstract read
In one paragraph

Article in Journal of photochemistry and photobiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Liubov M LifshitsDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, 76019-0065 United States.
John A RoqueDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, 76019-0065 United States.
Elamparuthi RamasamyDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, 76019-0065 United States.
Randolph P ThummelDepartment of Chemistry, University of Houston, 112 Fleming Building, Houston, Texas, 77204-5003, USA.
Colin G CameronDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, 76019-0065 United States.ORCID 0000-0003-0978-0894
Sherri A McFarlandDepartment of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, 76019-0065 United States.ORCID 0000-0002-8028-5055
The University of Texas at Arlington · USUniversity of Houston · USUniversity of North Carolina at Greensboro · US

Funding

Immunomodulating Ruthenium Metal Complexes for Melanoma PhotodynamicTherapyR01CA222227 · NCI · UNIVERSITY OF TEXAS ARLINGTON · PI GUJAR, SHASHI, MCFARLAND, SHERRI · 2018 to 2022
$2.6M
NCI NIH HHS R01 CA222227
6 · The paper itself

Abstract

A family of complexes of the type [Ru(tpbn)(IP-R)(4-pic)]Cl

Indexed as

intraligand (IL)melanomametal-to-ligand charge transfer (MLCT)near-infrared (NIR)photodynamic therapyRuthenium

Identifiers

PMID35419549
PMCPMC9000368
OpenAlexW3198990617

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.